Search research articles
Contact Us
Filters
Showing results (941-950 of 996) with videos related to
Page
of 100
Sort By:
Nature Genetics
|
September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A Hunter Shain, Maria Garrido, Thomas Botton, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
Hannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F Favero, N McGranahan, M Salm, et al.
Cell
|
October 7, 2017
Cohesin Loss Eliminates All Loop Domains
Suhas S P Rao, Su-Chen Huang, Brian Glenn St Hilaire, et al.
Research Square
|
January 16, 2026
Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
Jalees Rehman, Marcin Kwissa, Manikannan Mathayan, et al.
European Heart Journal
|
February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria
Frank I Marcus, William J McKenna, Duane Sherrill, et al.
Journal of Hematology & Oncology
|
June 6, 2025
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies
Quchang Ouyang, Jordi Rodon, Yan Liang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2022
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
Rachel E Sanborn, Michael J Pishvaian, Margaret K Callahan, et al.
Circulation
|
February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria
Frank I Marcus, William J McKenna, Duane Sherrill, et al.
Page
of 100
Search research articles
Search
Showing results (941-950 of 996) with videos related to
Sort By:
Page
of 100
Nature Genetics
|
September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A Hunter Shain, Maria Garrido, Thomas Botton, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
Hannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F Favero, N McGranahan, M Salm, et al.
Cell
|
October 7, 2017
Cohesin Loss Eliminates All Loop Domains
Suhas S P Rao, Su-Chen Huang, Brian Glenn St Hilaire, et al.
Research Square
|
January 16, 2026
Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
Jalees Rehman, Marcin Kwissa, Manikannan Mathayan, et al.
European Heart Journal
|
February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria
Frank I Marcus, William J McKenna, Duane Sherrill, et al.
Journal of Hematology & Oncology
|
June 6, 2025
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies
Quchang Ouyang, Jordi Rodon, Yan Liang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2022
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
Rachel E Sanborn, Michael J Pishvaian, Margaret K Callahan, et al.
Circulation
|
February 23, 2010
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria
Frank I Marcus, William J McKenna, Duane Sherrill, et al.
Page
of 100